Stocktoria
U S PHYSICAL THERAPY INC /NV USPH
U S PHYSICAL THERAPY INC /NV (USPH) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 2.71% (safety: stretched). FY2025 revenue was $781.0M at a 5.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.57 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.001 |
| Retained earnings / assets | 0.189 |
| EBIT / assets | 0.072 |
| Equity / liabilities | 1.099 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| USPH | U S PHYSICAL THERAPY INC /NV | 6/9 | 2.26 | 25.5 | +16.3% |
| INNV | InnovAge Holding Corp. | 6/9 | 0.08 | — | +11.8% |
| PNTG | Pennant Group, Inc. | 3/9 | 1.45 | 42.2 | +36.3% |
| WGS | GeneDx Holdings Corp. | 6/9 | -5.22 | — | +40% |
| DCGO | DocGo Inc. | 4/9 | -4.05 | — | -47.7% |
| OMDA | Omada Health, Inc. | 6/9 | 2.28 | — | +53.2% |
| TALK | Talkspace, Inc. | 6/9 | 5.28 | 112.2 | +22% |
About U S PHYSICAL THERAPY INC /NV
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
FAQ
Is USPH financially healthy?
U S PHYSICAL THERAPY INC /NV's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does USPH pay a dividend, and is it safe?
Yes. U S PHYSICAL THERAPY INC /NV pays a dividend yielding about 2.71% with a 69.1% payout ratio, rated “stretched” for safety.
How profitable is USPH?
In FY2025, U S PHYSICAL THERAPY INC /NV had a net margin of 5.1% and a return on equity of 8.3%.
Is USPH overvalued or undervalued?
U S PHYSICAL THERAPY INC /NV trades at about 57.7× trailing earnings — above its 10-year norm (10-year range 23.9×–72.1×, median 47.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for USPH?
The average Wall-Street price target for U S PHYSICAL THERAPY INC /NV is $93.67, about 14.3% above the recent price, from 6 analysts (consensus: buy).
Is USPH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on U S PHYSICAL THERAPY INC /NV: a Piotroski F-score of 6/9, an Altman Z″ in the grey zone, a P/E of about 25.5×, a dividend yield of 2.71%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.